The synthesis of two new A‐ring precursors, useful for the convergent assembly of 2α‐ethyl and 2β‐ethyl derivatives of 19‐nor‐1α,25‐dihydroxyvitamin D3, is described. These building blocks were prepared in 14 steps from quinic acid, which led to a new and practical synthesis of 2α‐ethyl‐14‐epi‐19‐nor‐20‐epi‐23‐yne‐1,25(OH)2D3, an analog that shows a remarkably low calcemic effect in mice, while retaining the ability to promote cell differentiation and to inhibit cell proliferation in a number of human cancer cell lines.